<p>Cells were treated with TGF-β1 (5 ng/ml) for the indicated time periods. Kinase activation was determined by western blot analysis using phosphospecific antibodies. As controls, the protein levels of Smad2, ERK1/2, p38MAPK and JNK were determined using corresponding non-phosphorylated form antibodies. Results of densitometric analysis, expressed as a ratio between phospho- and non-phospho-antibody, from three independent experiments were shown. *P<0.05 vs. control.</p
<p>(<b>A</b>) Fold change in expression levels of two smad regulated genes, PAI-1 and smad7, relativ...
<p>RPMCs were infected with Ad-DN-JNK1 or Ad-control for 24 hours and treated with, or without, 10 n...
<p>SBOT3.1 and MPSC1 cells were treated with 50 ng/ml EGF for the indicated durations. Phosphorylati...
<p>(A) Smad2 activation was not affected by inhibition of ERK or P38 MAPK pathways. ADPKD cyst-linin...
<p>(<b>A</b>) AKR-2B and NIH 3T3 fibroblast were treated with TGF-β (2 ng/ml) for times ranging from...
<p>(A) TGF-β1 treatment (1–10 ng/mL, 24 h). (B) TGF-β1 treatment (5 ng/mL, 6–36 h). Top panels were ...
<p>THSF cells were incubated with TGF-β1 (3 ng/ml) for the times indicated. The total and phosphoryl...
<p><b>A:</b> NMuMG cells were either left untreated or were treated with TGFβ1 (10 ng/ml) for 48 hou...
<p>(<b>A</b>) Western blots from AKR-2B fibroblast cell lysates treated with TGF-β (2 ng/ml) for the...
<p>(<b>A</b>) Lysates from Huh7.5 or Huh7.5-FL cells collected at the indicated time points were blo...
<p>Cells were pretreated with rosiglitazone for 1 h, and then incubated with rosiglitazone in the pr...
<p>(A) RPE cells were cultured in the absence or presence of TGFβ2 for 15min, 30 min and 60 min, the...
<p>(A) HK-2 cells that were treated with or without TGF-β1 (5 ng/ml) as well as Erk phosphorylation ...
<p>(<b>A</b>) Cells were stimulated with indicated concentrations of TGF-β1 (0.1 ng/ml; 1.0 ng/ml), ...
<p>Cultured NRK-49F cells were incubated with TGF-β1 (1 ng/mL) for 15 mins–180 mins in the presence ...
<p>(<b>A</b>) Fold change in expression levels of two smad regulated genes, PAI-1 and smad7, relativ...
<p>RPMCs were infected with Ad-DN-JNK1 or Ad-control for 24 hours and treated with, or without, 10 n...
<p>SBOT3.1 and MPSC1 cells were treated with 50 ng/ml EGF for the indicated durations. Phosphorylati...
<p>(A) Smad2 activation was not affected by inhibition of ERK or P38 MAPK pathways. ADPKD cyst-linin...
<p>(<b>A</b>) AKR-2B and NIH 3T3 fibroblast were treated with TGF-β (2 ng/ml) for times ranging from...
<p>(A) TGF-β1 treatment (1–10 ng/mL, 24 h). (B) TGF-β1 treatment (5 ng/mL, 6–36 h). Top panels were ...
<p>THSF cells were incubated with TGF-β1 (3 ng/ml) for the times indicated. The total and phosphoryl...
<p><b>A:</b> NMuMG cells were either left untreated or were treated with TGFβ1 (10 ng/ml) for 48 hou...
<p>(<b>A</b>) Western blots from AKR-2B fibroblast cell lysates treated with TGF-β (2 ng/ml) for the...
<p>(<b>A</b>) Lysates from Huh7.5 or Huh7.5-FL cells collected at the indicated time points were blo...
<p>Cells were pretreated with rosiglitazone for 1 h, and then incubated with rosiglitazone in the pr...
<p>(A) RPE cells were cultured in the absence or presence of TGFβ2 for 15min, 30 min and 60 min, the...
<p>(A) HK-2 cells that were treated with or without TGF-β1 (5 ng/ml) as well as Erk phosphorylation ...
<p>(<b>A</b>) Cells were stimulated with indicated concentrations of TGF-β1 (0.1 ng/ml; 1.0 ng/ml), ...
<p>Cultured NRK-49F cells were incubated with TGF-β1 (1 ng/mL) for 15 mins–180 mins in the presence ...
<p>(<b>A</b>) Fold change in expression levels of two smad regulated genes, PAI-1 and smad7, relativ...
<p>RPMCs were infected with Ad-DN-JNK1 or Ad-control for 24 hours and treated with, or without, 10 n...
<p>SBOT3.1 and MPSC1 cells were treated with 50 ng/ml EGF for the indicated durations. Phosphorylati...